a 2016

Analysis of clonal evolution in chronic lymphocytic leukemia from inactive to symptomatic disease prior treatment using whole-exome sequencing.

HERNÁNDEZ-SÁNCHEZ, M., Lenka RADOVÁ, Jana KOTAŠKOVÁ, D. TAMBORERO, A.E. RODRIGUEZ et. al.

Basic information

Original name

Analysis of clonal evolution in chronic lymphocytic leukemia from inactive to symptomatic disease prior treatment using whole-exome sequencing.

Authors

HERNÁNDEZ-SÁNCHEZ, M., Lenka RADOVÁ, Jana KOTAŠKOVÁ, D. TAMBORERO, A.E. RODRIGUEZ, Karla PLEVOVÁ, M. ABÁIGAR, Vasileios BIKOS, R. BENITO, Sylvia TAKÁČOVÁ, M. QUIJADA, A. ÁFRICA MARTÍN, M. ALCOCEBA, A. GARCÍA DE COCA, Michael DOUBEK, M. GONZÁLEZ, N. LOPEZ-BIGAS, Šárka POSPÍŠILOVÁ and J. HERNÁNDEZ-RIVAS

Edition

Blood (58th ASH Annual Meeting and Exposition, San Diego, USA, prosinec 2016), 2016

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology
Změněno: 19/4/2018 11:34, Jana Dvořáková

Links

LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
TE02000058, research and development project
Name: Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu (Acronym: MOLDIMED)
Investor: Technology Agency of the Czech Republic
15-31834A, interní kód MU
(CEP code: NV15-31834A)
Name: Vliv selekce genomických poškození na průběh chronické lymfocytární leukémie
Investor: Ministry of Health of the CR
306242, interní kód MU
Name: NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)
Investor: European Union, Cooperation
7E13008, research and development project
Name: Next Generation Sequencing Platform for Targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)
Investor: Ministry of Education, Youth and Sports of the CR